Ponatinib Induced Improvement of Cutaneous Lesions Associated to Accelerated Phase of Ph-Positive Chronic Myeloid Leukemia. Mediterr J Hematol Infect Dis 2016, 8, e2016016. https://doi.org/10.4084/mjhid.2016.016.